KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Operating Expenses (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Operating Expenses for 7 consecutive years, with $521.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 53.35% year-over-year to $521.0 million, compared with a TTM value of $1.5 billion through Dec 2025, up 32.6%, and an annual FY2025 reading of $200000.0, down 99.89% over the prior year.
  • Operating Expenses was $521.0 million for Q3 2025 at Clover Health Investments, up from $488.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.0 billion in Q4 2022 and bottomed at -$200.5 million in Q4 2023.
  • Average Operating Expenses over 5 years is $526.7 million, with a median of $521.0 million recorded in 2025.
  • The sharpest move saw Operating Expenses soared 24688.19% in 2021, then plummeted 119.93% in 2023.
  • Year by year, Operating Expenses stood at $618.8 million in 2021, then surged by 62.59% to $1.0 billion in 2022, then tumbled by 119.93% to -$200.5 million in 2023, then surged by 126.08% to $52.3 million in 2024, then soared by 896.49% to $521.0 million in 2025.
  • Business Quant data shows Operating Expenses for CLOV at $521.0 million in Q3 2025, $488.2 million in Q2 2025, and $463.6 million in Q1 2025.